ImmusanT, Inc. Presents Data From Multiple Studies Supporting Continued Development Of Nexvax2 Post author:Sam Post published:September 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Medpace Reports Fourth Quarter And Full Year 2016 Results February 27, 2017 Effective Immediately: OncoSec Names Former Advaxis Exec as New CEO November 7, 2017 Marrone Bio Innovations, Inc Closes $9.2 Million Public Offering Of Common Stock With Full Exercise Of Over-Allotment Option April 30, 2017
Marrone Bio Innovations, Inc Closes $9.2 Million Public Offering Of Common Stock With Full Exercise Of Over-Allotment Option April 30, 2017